GREAT POINT PARTNERS LLC Quant / Systematic

CIK: 0001281446 · Show all filings

Period: Q4 2015 (← Previous) (Next →)

Filing Date: Feb 16, 2016

Total Value ($000): $238,298 (100.0% shares, 0.0% debt)

Holdings (25)

ADAMAS PHARMACEUTICALS INC 17.1%
Value ($000) $40,705 Shares 1,437,335 Est. Cost $20.76 Unrealized
FIVE PRIME THERAPEUTICS INC 9.9%
Value ($000) $23,641 Shares 569,658 Est. Cost $20.62 Unrealized
ZOGENIX INC 8.8%
Value ($000) $20,856 Shares 1,414,927 Est. Cost $13.55 Unrealized
VNDA VANDA PHARMACEUTICALS INC 8.2%
Value ($000) $19,552 Shares 2,100,101 Est. Cost $11.18 Unrealized -10.8%
TETRAPHASE PHARMACEUTICALS I 8.2%
Value ($000) $19,458 Shares 1,940,000 Est. Cost $8.55 Unrealized
CONNECTURE INC 6.3%
Value ($000) $14,899 Shares 4,127,232 Est. Cost $9.01 Unrealized
ALCOBRA LTD 5.3%
Value ($000) $12,639 Shares 2,012,622 Est. Cost $5.99 Unrealized
EXEL EXELIXIS, INC 4.8%
Value ($000) $11,463 Shares 2,032,494 Est. Cost $5.47 Unrealized +2.2%
SYNERGY PHARMACEUTICALS DEL 3.7%
Value ($000) $8,771 Shares 1,546,888 Est. Cost $7.60 Unrealized
SUNESIS PHARMACEUTICALS INC 3.1%
Value ($000) $7,404 Shares 8,250,000 Est. Cost $1.47 Unrealized
GW PHARMACEUTICALS PLC 2.9%
Value ($000) $6,944 Shares 100,000 Est. Cost Unrealized
PARATEK PHARMACEUTICALS INC 2.8%
Value ($000) $6,743 Shares 355,459 Est. Cost $25.19 Unrealized
RAPTOR PHARMACEUTICAL CORP 2.8%
Value ($000) $6,669 Shares 1,282,527 Est. Cost $6.05 Unrealized
AUPH AURINIA PHARMACEUTICALS INC 2.6%
Value ($000) $6,160 Shares 2,457,144 Est. Cost $3.52 Unrealized -23.0%
OCERA THERAPEUTICS INC 2.6%
Value ($000) $6,127 Shares 1,963,777 Est. Cost $6.20 Unrealized
BOVIE MEDICAL CORP 2.4%
Value ($000) $5,628 Shares 2,680,000 Est. Cost $2.72 Unrealized
VCEL VERICEL CORP 2.3%
Value ($000) $5,382 Shares 2,086,028 Est. Cost $2.85 Unrealized -21.5%
ARADIGM CORP 1.7%
Value ($000) $3,982 Shares 1,002,962 Est. Cost $8.85 Unrealized
TENAX THERAPEUTICS INC 1.5%
Value ($000) $3,636 Shares 1,108,593 Est. Cost $3.93 Unrealized
CALADRIUS BIOSCIENCES INC 1.0%
Value ($000) $2,429 Shares 2,248,781 Est. Cost $1.87 Unrealized
TRANSITION THERAPEUTICS INC 0.7%
Value ($000) $1,645 Shares 856,602 Est. Cost $1.85 Unrealized
FLEXION THERAPEUTICS INC 0.6%
Value ($000) $1,505 Shares 78,100 Est. Cost Unrealized
CYTK CYTOKINETICS INC 0.5%
Value ($000) $1,117 Shares 106,800 Est. Cost Unrealized
MANNKIND CORP 0.3%
Value ($000) $729 Shares 503,000 Est. Cost Unrealized
STREAMLINE HEALTH SOLUTIONS 0.1%
Value ($000) $214 Shares 151,611 Est. Cost $6.45 Unrealized